Atara Biotherapeutics, Inc.
USD9.90
-0.38 (-3.70%)
CEO
Anhco Nguyen
IPO Date
2014-10-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.12
Prev. Close
$10.28
Day Low
$9.83
Day High
$10.42
52W Low
$3.92
52W High
$19.14
Market Cap
$0.09B
Volume
0.06M
| 2,414 |
| $9.13 |
| 11 May 2026 | Panacea Innovation Ltd | 10 percent owner | S-Sale | Disposed | 313,446 | $10.10 |
| 11 May 2026 | EcoR1 Capital, LLC | 10 percent owner | P-Purchase | Acquired | 507,407 | $9.35 |
| 11 May 2026 | EcoR1 Capital, LLC | 10 percent owner | Disposed | 0 | $0.00 |
| 19 Mar 2026 | Panacea Innovation Ltd | 10 percent owner | M-Exempt | Acquired | 259,163 | $0.00 |
| 19 Mar 2026 | Panacea Innovation Ltd | 10 percent owner | F-InKind | Disposed | 5 | $5.23 |
| 19 Mar 2026 | Panacea Innovation Ltd | 10 percent owner | M-Exempt | Disposed | 259,163 | $0.00 |
| 11 Mar 2026 | Nguyen AnhCo | director, officer: President and CEO | A-Award | Acquired | 81,100 | $0.00 |
| 11 Mar 2026 | Grant-Huerta Yanina | Chief Accounting Officer | A-Award | Acquired | 20,300 | $0.00 |